Tag Archives: The Stem Cell Blog

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients – New York Times

Continue reading

2017-08-12 NEWS

New York Times

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
New York Times
With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research. There are too many experimental cancer …

and more »

Continue reading

2017-08-12 NEWS

Salon

Stem cell therapy for heart failure gets a gold-standard trial
Salon
One company, Melbourne, Australia–based Mesoblast, is already in late-stage clinical trials, treating hundreds of chronic heart failure patients with stem cell precursors drawn from healthy donors’ hip bones. A randomized trial that includes a placebo

Continue reading

2017-08-12 NEWS

Sports Perspectives

Editas Medicine’s (EDIT) CEO Katrine Bosley on Q2 2017 Results – Earnings Call Transcript
Seeking Alpha
Cpf1 is a new CRISPR genome-editing system that substantially expands the range of genomic sites we can target, and it may also have advantages in terms of specificity, manufacturing and delivery. In addition, Cpf1 may enable us to achieve more
Editas Medicine Announces Second Quarter 2017 Results and UpdateNasdaq
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 15.5% Above Its 50 Day Moving AverageHugoPress

all 106 news articles »

Continue reading

2017-08-12 NEWS

Students help to save lives through stem cell donations
Falmouth Packet
Students at the Penryn Campus are hoping to save lives by donating their stem cells to strangers who are fighting cancer. A campaign set up to help students at the University of Exeter at Tremough to “do good” has resulted in two people working with